Please login to the form below

Not currently logged in
Email:
Password:

bempedoic acid

This page shows the latest bempedoic acid news and features for those working in and with pharma, biotech and healthcare.

Esperion gets FDA thumbs up for cholesterol drug Nexletol

Esperion gets FDA thumbs up for cholesterol drug Nexletol

Bempedoic acid is described as a first-in-class ATP citrate lyase (ACL) inhibitor that inhibits cholesterol synthesis in the liver. ... The company has also filed bempedoic acid in Europe, as well as a combination pill with ezetimibe, filed with both the

Latest news

  • Dupixent helps put Sanofi back on growth track Dupixent helps put Sanofi back on growth track

    US. However, both these drugs are facing the threat of competition from new oral therapies such as Esperion’s bempedoic acid, which could be filed for approval in early 2019, and

  • Esperion craters as deaths mar atherosclerosis drug study Esperion craters as deaths mar atherosclerosis drug study

    Esperion has seen almost a fifth of the value wiped off its shares as a phase III trial of its atherosclerosis candidate bempedoic acid revealed a three-fold increase in deaths ... The pivotal trial, which was comparing bempedoic acid to placebo given on

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...